A Diagnostic Assay Based on MicroRNA Expression Accurately Identifies Malignant Pleural Mesothelioma
Hila Benjamin(Rosetta Genomics (Israel)), Dalia Cohen(Regulus Therapeutics (United States)), Shai Rosenwald(Rosetta Genomics (Israel)), Hadas Gibori(Tel Aviv University), Zvi Bentwich(Ben-Gurion University of the Negev), Marina Perelman(Tel Aviv University), Ranit Aharonov(Unknown), Eti Meiri(Rosetta Genomics (Israel)), Nitzan Rosenfeld(Queen Mary University of London), Naama Barabash(Rosetta Genomics (Israel)), Yaron Goren(Rosetta Genomics (Israel)), Eran Goren(Rosetta Genomics (Israel)), Ayelet Chajut(Rosetta Genomics (Israel)), Lahav Cohen(Rosetta Genomics (Israel)), Tina Bocker Edmonston(The University of Texas MD Anderson Cancer Center), Karin Ashkenazi(Tel Aviv University), Sara Morgenstern(Tel Aviv University), Iris Barshack(Tel Aviv University), Danit Lebanony(Rosetta Genomics (Israel))
Cited by 122
Related Papers
Liquid biopsies come of age: towards implementation of circulating tumour DNA
|Nature reviews. Cancer|2017|2.6k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Dynamics of the p53-Mdm2 feedback loop in individual cells
|Nature Genetics|2004|1k
MicroRNAs accurately identify cancer tissue origin
|Nature Biotechnology|2008|987